Skip to main content

The Corneal Pocket Assay

  • Protocol
  • First Online:
Vascular Morphogenesis

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1214))

Abstract

The cornea in most species is physiologically avascular, and thus this assay allows the measurement of newly formed vessels. The continuous monitoring of neovascular growth in the same animal allows the evaluation of drugs acting as suppressors or stimulators of angiogenesis. Under anesthesia a micropocket is produced in the cornea thickness and the angiogenesis stimulus (tumor tissue, cell suspension, growth factor) is placed into the pocket in order to induce vascular outgrowth from the limbal capillaries. Neovascular development and progression can be modified by the presence of locally released or applied inhibitory factors or by systemic treatments. In this chapter the experimental details of the avascular cornea assay, the technical challenges, and advantages and disadvantages in different species are discussed. Protocols for local drug treatment and tissue sampling for histology and pharmacokinetic profile are reported.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Jain RK, Schlenger K, Hockel M, Yuan F (1997) Quantitative angiogenesis assays: progress and problems. Nat Med 3:1203–1208

    Article  CAS  PubMed  Google Scholar 

  2. Chang JH, Gabison EE, Kato T, Azar DT (2001) Corneal neovascularization. Curr Opin Ophthalmol 12:242–249

    Article  CAS  PubMed  Google Scholar 

  3. Ellenberg D, Azar DT, Hallak JA, Tobaigy F, Han KY, Jain S et al (2010) Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res 29:208–248

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Maddula S, Davis DK, Maddula S, Burrow MK, Ambati BK (2011) Horizons in therapy for corneal angiogenesis. Ophthalmology 118:591–599

    Article  PubMed Central  PubMed  Google Scholar 

  5. Ambati BK, Nozaki M, Singh N, Takeda A, Jani PD, Suthar T et al (2006) Corneal avascularity is due to soluble VEGF receptor-1. Nature 443:993–997

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Gimbrone M Jr, Cotran R, Leapman SB, Folkman J (1974) Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst 52:413–427

    PubMed  Google Scholar 

  7. Langer R, Folkman J (1976) Polymers for the sustained release of proteins and other macromolecules. Nature 363:797–800

    Article  Google Scholar 

  8. Brem SS, Gullino PM, Medina D (1977) Angiogenesis: a marker for neoplastic transformation of mammary papillary hyperplasia. Science 195(4281):880–882

    Article  CAS  PubMed  Google Scholar 

  9. Cervenak L, Morbidelli L, Donati D, Donnini S, Kambayashi T, Wilson J et al (2000) Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by Interleukin-10. Blood 96:2568–2573

    CAS  PubMed  Google Scholar 

  10. Woolard J, Wang WY, Bevan HS, Qiu Y, Morbidelli L, Pritchard-Jones RO et al (2004) VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res 64:7822–7835

    Article  CAS  PubMed  Google Scholar 

  11. Marconcini L, Marchio S, Morbidelli L, Cartocci E, Albini A, Ziche M et al (1999) c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. Proc Natl Acad Sci U S A 96:9671–9676

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. Brem H, Folkman J (1975) Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 141:427–439

    Article  CAS  PubMed  Google Scholar 

  13. Bard RH, Mydlo JH, Freed SZ (1986) Detection of tumor angiogenesis factor in adenocarcinoma of kidney. Urology 27:447–450

    Article  CAS  PubMed  Google Scholar 

  14. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA et al (1998) Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90:587–596

    Article  CAS  PubMed  Google Scholar 

  15. da Silva BB, da Silva RG Jr, Borges US, da Silveira Filho MA, Pimentel IC et al (2005) Quantification of angiogenesis induced in rabbit cornea by breast carcinoma of women treated with tamoxifen. J Surg Oncol 90:77–80

    Article  PubMed  Google Scholar 

  16. Ziche M, Morbidelli L, Choudhuri R, Zhang H-T, Donnini S, Granger HJ et al (1997) Nitric oxide-synthase lies downstream of vascular endothelial growth factor but not basic fibroblast growth factor induced angiogenesis. J Clin Invest 99:2625–2634

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Lasagna N, Fantappiè O, Solazzo M, Morbidelli L, Marchetti S, Cipriani G et al (2006) Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines. Cancer Res 66:2673–2682

    Article  CAS  PubMed  Google Scholar 

  18. Ziche M, Morbidelli L (2009) Molecular regulation of tumour angiogenesis by nitric oxide. Eur Cytokine Netw 20:164–170

    CAS  PubMed  Google Scholar 

  19. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA et al (1994) Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94:2036–2044

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Monti M, Donnini S, Morbidelli L, Giachetti A, Mochly-Rosen D, Mignatti P et al (2013) PKCε activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting. J Mol Cell Cardiol 63:107–117

    Article  CAS  PubMed  Google Scholar 

  21. Muthukkaruppan V, Auerbach R (1979) Angiogenesis in the mouse cornea. Science 206:1416–1418

    Article  Google Scholar 

  22. Chen C, Parangi S, Tolentino MT, Folkman J (1995) A strategy to discover circulating angiogenesis inhibitors generated by human tumors. Cancer Res 55:4230–4233

    CAS  PubMed  Google Scholar 

  23. Voest EE, Kenyon BM, O’Really MS, Truitt G, D’Amato RJ, Folkman J (1995) Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87:581–586

    Article  CAS  PubMed  Google Scholar 

  24. Polverini PJ, Leibovich SJ (1984) Induction of neovascularization in vivo and endothelial cell proliferation in vitro by tumor associated macrophages. Lab Invest 51:635–642

    CAS  PubMed  Google Scholar 

  25. Ziche M, Jones J, Gullino PM (1982) Role of prostaglandin E1 and copper in angiogenesis. J Natl Cancer Inst 69:475–482

    CAS  PubMed  Google Scholar 

  26. Taraboletti G, Morbidelli L, Donnini S, Parenti A, Granger HJ, Giavazzi R et al (2000) The heparin binding 25 kDa fragment of thrombospondin-1 promotes angiogenesis and modulates gelatinases and TIMP-2 in endothelial cells. FASEB J 14:1674–1676

    CAS  PubMed  Google Scholar 

  27. Parenti A, Morbidelli L, Ledda F, Granger HJ, Ziche M (2001) The bradykinin/B1 receptor promotes angiogenesis by upregulation of endogenous FGF-2 in endothelium via the nitric oxide synthase pathway. FASEB J 15:1487–1489

    CAS  PubMed  Google Scholar 

  28. Morbidelli L, Donnini S, Chillemi F, Giachetti A, Ziche M (2003) Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin. Clin Cancer Res 9:5358–5369

    CAS  PubMed  Google Scholar 

  29. Bagli E, Stefaniotou M, Morbidelli L, Ziche M, Psillas K, Murphy C et al (2004) Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3′-kinase activity. Cancer Res 64:7936–7946

    Article  CAS  PubMed  Google Scholar 

  30. Donnini S, Finetti F, Lusini L, Morbidelli L, Cheynier V, Barron D et al (2006) Divergent effects of quercetin conjugates on angiogenesis. Br J Nutr 95:1016–1023

    Article  CAS  PubMed  Google Scholar 

  31. Ziche M, Alessandri G, Gullino PM (1989) Gangliosides promote the angiogenic response. Lab Invest 61:629–634

    CAS  PubMed  Google Scholar 

  32. Cantara S, Donnini S, Morbidelli L, Giachetti A, Schulz R, Memo M et al (2004) Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2. FASEB J 18:1943–1945

    CAS  PubMed  Google Scholar 

  33. Federman JL, Brown GC, Felberg NT, Felton SM (1980) Experimental ocular angiogenesis. Am J Ophthalmol 89:231–237

    Article  CAS  PubMed  Google Scholar 

  34. Presta M, Rusnati M, Belleri M, Morbidelli L, Ziche M, Ribatti D (1999) Purine analog 6-methylmercaptopurine ribose inhibits early and late phases of the angiogenesis process. Cancer Res 59:2417–2424

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The work was supported by the Italian Ministry of University (MIUR), the Italian Association for Cancer Research (AIRC) to M.Z. and Istituto Toscano Tumori (ITT) to L.M.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marina Ziche M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer Science+Business Media New York

About this protocol

Cite this protocol

Ziche, M., Morbidelli, L. (2015). The Corneal Pocket Assay. In: Ribatti, D. (eds) Vascular Morphogenesis. Methods in Molecular Biology, vol 1214. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1462-3_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-1462-3_2

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-1461-6

  • Online ISBN: 978-1-4939-1462-3

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics